Showing results (881-890 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|December 2, 2011
Tissue-engineered airway: a regenerative solutionP Jungebluth, G Moll, S Baiguera, et al.Clinical Pharmacology and Therapeutics|December 2, 2011
Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosusG J DennisClinical Pharmacology and Therapeutics|May 3, 2012
Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypassF T Billings, J M Balaguer, Yu C, et al.Clinical Pharmacology and Therapeutics|May 3, 2012
Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trialP Hoever, G Dorffner, H Beneš, et al.Clinical Pharmacology and Therapeutics|November 18, 2011
Model-based meta-analysis for comparative efficacy and safety: application in drug development and beyondJ W Mandema, M Gibbs, R A Boyd, et al.Clinical Pharmacology and Therapeutics|November 18, 2011
PON1 Q192R and clopidogrel: a case of the winner's curse or inadequate replication?J A Talameh, H L McLeodClinical Pharmacology and Therapeutics|February 3, 2012
Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteersS Oswald, H E Meyer zu Schwabedissen, A Nassif, et al.Clinical Pharmacology and Therapeutics|February 17, 2012
FDA review divisions: performance levels and the impact on drug sponsorsC-P Milne, K I KaitinClinical Pharmacology and Therapeutics|February 21, 2012
Heterotropic effects on drug-metabolizing enzyme activities: in vitro curiosity emerges as a clinically meaningful phenomenon (perhaps?)R S ObachClinical Pharmacology and Therapeutics|February 21, 2012
Pharmacogenomic testing: knowing more, doing betterJ E Lunshof, D GurwitzPageof 941